UCB SA (UCB)

87.08
+0.68(+0.79%)
  • Volume:
    295,548
  • Bid/Ask:
    0.00/0.00
  • Day's Range:
    86.18 - 87.60
  • Type:Equity
  • Market:Belgium
  • ISIN:BE0003739530

UCB Overview

Prev. Close
86.4
Day's Range
86.18-87.6
Revenue
5.52B
Open
86.64
52 wk Range
74.32-107.4
EPS
4.77
Volume
295,548
Market Cap
16.44B
Dividend (Yield)
0.89
(1.03%)
Average Volume (3m)
225,298
P/E Ratio
18.13
Beta
0.47
1-Year Change
-1.2%
Shares Outstanding
188,811,567
Next Earnings Date
23 Feb 2022
What is your sentiment on UCB SA?
or
Market is currently closed. Voting is open during market hours.

UCB SA Company Profile

Employees
7600
Market
Belgium

Ucb SA is a Belgium-based biopharmaceutical and specialty chemical company that specializes in two therapeutic areas: diseases of the central nervous system (CNS) and immunology. In the area of central nervous system disorders, the Company is focused on epilepsy, diabetic neuropathic pain, multiple sclerosis, fibromyalgia, restless legs syndrome and Parkinson’s disease, and the area of immunology includes, bone loss disorders, Crohn’s disease, rheumatoid arthritis and respiratory disease. In addition to its core fields of business, Ucb SA delivers molecule solutions to specialists for use in the treatment of severe diseases. Its product portfolio includes drugs, such as Neupro, Vimpat, Cimzia, among others. Ucb SA also operates in primary care to support specialist products that are administered by primary care physicians.

Read More

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong SellStrong SellSellStrong SellNeutral
Technical IndicatorsSellSellStrong SellStrong SellNeutral
SummaryStrong SellStrong SellStrong SellStrong SellNeutral
    Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
    Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.